NATCO Pharma shares sinks 28% in 2 days on Q3 earnings miss, brokerage downgrade
NATCO Pharma shares tumbled 10% on Friday, extending a two-day slump to 28% after weak Q3 results and a target price cut by ...
Natco Pharma, Orchid Pharma, NBCC India, IPCA Labs: Stock price targets
Stock analysts noted Natco Pharma’s missed consensus Q3 estimates on both revenue and Ebitda margin fronts due to lack of ...
devdiscourse2d
NATCO Pharma Stocks Plummet Amid Profit Slump
Shares of NATCO Pharma Ltd fell by 20% following a report of a 37.75% decline in consolidated net profit for the December quarter. The company cites a significant drop in formulation exports as a key ...
Daily2d
Dr Pavan Ganapati Bhat resigns as Director & Executive Vice President (Technical Operations) of Natco Pharma
Telangana: Natco Pharma has announced the resignation of Dr Pavan Ganapati Bhat as Director & Executive Vice President ...
Hosted on MSN2d
NATCO Pharma share price tanks 20% after Q3 results - Check highlights
NATCO Pharma is a smallcap company. It is a constituent of BSE 500 index. The pharma stock crashed 20 per cent after it ...
devdiscourse2d
NATCO Pharma's Shares Plummet Amid Massive Profit Decline
NATCO Pharma Ltd's shares dropped by nearly 20% following a reported 37.75% decrease in consolidated net profit for the December quarter. The decline is attributed to falling formulation exports and ...
Daily5d
Natco Pharma gets final approval for Bosentan tablets for oral suspension
Hyderabad: NATCO Pharma Limited has announced final approval of its Abbreviated New Drug Application (ANDA) for Bosentan ...